A Study of DB-1303 in Advanced/Metastatic Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: HER2-positive Advanced Solid Tumor
Interventions: BIOLOGICAL: DB-1303|DRUG: Pertuzumab Injection|DRUG: Ritonavir|DRUG: Itraconazole
Sponsor: DualityBio Inc.